샘플 요청 목록

 카트 문의
시장보고서
상품코드
1760979

세계의 신경혈관 기기/중재적 신경 기기 시장

Neurovascular Devices / Interventional Neurology
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신경혈관 기기/중재적 신경 기기 세계 시장은 2030년까지 61억 달러에 달할 전망

2024년에 40억 달러로 추정되는 신경혈관 기기/중재적 신경 기기 세계 시장은 2030년에는 61억 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 7.3%로 성장할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 동맥류 코일링 및 색전 기기는 CAGR 8.2%를 기록하며 분석 기간 종료까지 27억 달러에 달할 것으로 예측됩니다. 신경혈전제거 기기 부문의 성장률은 분석 기간 동안 CAGR 6.5%로 추정됩니다.

미국 시장은 11억 달러, 중국은 CAGR 6.9%로 성장할 것으로 예측

미국의 신경혈관 기기/중재적 신경 기기 시장은 2024년에 11억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 9억 3,860만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.9%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 6.9%와 5.7%로 예측됩니다. 유럽에서는 독일이 CAGR 5.8%로 성장할 것으로 예측됩니다.

세계의 신경혈관 기기/중재적 신경 기기 시장 - 주요 동향과 촉진요인 정리

신경혈관 기기란 무엇이며, 신경학에서 왜 중요한가?

신경혈관 기기는 뇌와 척추의 혈관에 영향을 미치는 장애를 치료하기 위해 고안된 의료기기입니다. 뇌졸중, 동맥류, 동정맥 기형(AVM), 기타 중추신경계 혈관 질환의 치료 등에 필수적으로 사용됩니다. 이 카테고리에는 색전 코일, 신경혈관 스텐트, 혈전제거 기기, 카테터 등의 제품이 포함되며, 중재적 신경과 전문의가 최소침습적 시술을 통해 정상적인 혈류를 회복하고 출혈과 허혈의 위험을 줄일 수 있도록 도와줍니다.

신경혈관 기기의 중요성은 이러한 기기를 사용하여 뇌혈관 질환을 치료하는 데 중점을 두는 분야인 중재적 신경학의 부상과 함께 비약적으로 증가하고 있습니다. 뇌졸중은 전 세계 사망과 장애의 주요 원인 중 하나이며, 이러한 기구를 사용하여 치료하는 주요 질환입니다. 최소침습 신경혈관중재술은 기존 개두술에 비해 회복시간 단축, 합병증 위험 감소, 성공률 향상 등 큰 장점이 있습니다. 전 세계적으로 뇌졸중과 동맥류에 대한 부담이 증가하는 가운데, 신경혈관 기기는 환자의 생명을 구하고 결과를 개선하는 데 중요한 역할을 하고 있습니다.

신경혈관 기기 시장은 어떻게 진화하고 있는가?

신경혈관 기기 시장은 기술 발전과 최소침습적 시술에 대한 선호도가 높아지면서 빠르게 진화하고 있습니다. 시장을 형성하는 주요 트렌드 중 하나는 허혈성 뇌졸중 환자의 혈전제거에 사용되는 차세대 혈전제거 기기의 개발입니다. 이러한 장치는 끊임없는 기술 혁신을 통해 보다 신속하고 효과적인 혈전제거를 가능하게 하고, 뇌졸중 발병부터 치료까지 걸리는 시간을 단축하여 환자의 예후를 개선하고 있습니다. 기계적 혈전제거술은 현재 급성 허혈성 뇌졸중 치료의 표준으로 여겨지고 있으며, 이는 이러한 장비에 대한 수요 급증으로 이어지고 있습니다.

또 다른 큰 추세는 복잡한 뇌동맥류 치료에 유량분배기의 사용이 증가하고 있다는 점입니다. 유량 전환기는 동맥류에서 혈류를 동맥류로부터 멀리 떨어뜨려 혈관의 치유를 촉진하고 파열을 방지하도록 설계된 스텐트 같은 장치입니다. 이 장치는 큰 동맥류나 접근하기 어려운 동맥류에 대해 기존의 코일링 시술보다 덜 침습적이고 효과적인 대체 시술을 제공합니다. 또한, 이 시장에서는 뇌에 정확하게 치료제를 전달하는 데 필수적인 가이드와이어 및 마이크로카테터와 같은 신경혈관 접근 제품에 대한 수요도 증가하고 있습니다.

어떤 상황들이 신경혈관 기기의 채택을 촉진하고 있는가?

여러 질환이 신경혈관 기기의 채택 증가를 촉진하고 있지만, 그 중에서도 뇌졸중이 가장 중요합니다. 뇌졸중, 특히 혈전으로 인한 허혈성 뇌졸중은 혈류를 회복하고 뇌의 영구적인 손상을 예방하기 위해 즉각적인 개입이 필요합니다. 스텐트 리트리버와 흡입 카테터와 같은 신경혈관 기구는 이러한 생명을 구하는 데 필수적입니다. 혈관이 파열되어 발생하는 출혈성 뇌졸중에서도 동맥류 클립, 코일, 유량 전환기 등의 기구를 사용하여 추가 출혈을 막고 환자를 안정화시켜야 합니다.

동맥류는 파열 시 생명을 위협하는 출혈로 이어질 수 있기 때문에 동맥류 치료의 또 다른 큰 원동력이 되고 있습니다. 색전 코일이나 유량 전환기와 같은 장치를 이용한 최소침습적 개입을 통해 개복 수술 없이 동맥류를 표적 치료할 수 있습니다. 뇌동정맥기형(AVM)과 경막동정맥루(DAVF)(뇌의 동맥과 정맥의 비정상적인 결합)도 신경혈관 기기를 사용하여 치료할 수 있습니다. 이러한 질환은 종종 색전술이나 외과적 절제술이 필요하지만, 모두 파열이나 출혈의 위험을 줄이기 위해 특수 기구에 의존하고 있습니다.

신경혈관 기기 시장의 주요 성장 촉진요인은 무엇인가?

신경혈관 기기 시장의 성장은 몇 가지 중요한 요인에 의해 주도되고 있습니다. 전 세계적으로 뇌졸중과 뇌동맥류의 유병률 증가는 특히 고령화로 인해 이러한 질환의 위험이 증가함에 따라 주요 촉진요인으로 작용하고 있습니다. 또 다른 중요한 요인은 환자의 회복 시간 단축, 입원 기간 단축, 합병증 발생률 감소를 가져오는 최소침습적 수술에 대한 수요가 증가하고 있다는 점입니다. 중재적 신경학이 계속 발전함에 따라 혈전제거 시스템, 스텐트, 색전 제품 등 첨단 장비에 대한 수요가 증가하고 있습니다.

신경혈관 기기의 기술적 진보도 시장 성장을 견인하고 있습니다. 정확성과 안전성을 높인 차세대 혈전제거 기기, 유량 전환기, 색전 코일 등의 개발로 치료 가능한 질환이 확대되고 있습니다. 또한, 특히 신흥 시장에서 헬스케어 인프라에 대한 투자 증가로 신경혈관 치료 접근성이 향상되고 있습니다. 뇌졸중 관련 사망률 감소와 예후 개선에 초점을 맞춘 정부의 노력과 뇌졸중 예방 및 조기 치료에 대한 인식이 높아지면서 시장 확대에 기여하고 있습니다.

부문

제품 유형(동맥류 코일링·색전 기기, 신경혈전제거 기기, 뇌 풍선 혈관성형·스텐트 유치 시스템, 서포트 장비), 질환 병태(뇌동맥류, 허혈성 뇌졸중, 동정맥기형·누공, 기타 질환 병태), 최종사용자(병원, 외래 수술 센터, 기타 최종사용자)

조사 대상 기업 사례(총 12개사)

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W.L. Gore & Associates, Inc.

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

ksm 25.07.07

Global Neurovascular Devices / Interventional Neurology Market to Reach US$6.1 Billion by 2030

The global market for Neurovascular Devices / Interventional Neurology estimated at US$4.0 Billion in the year 2024, is expected to reach US$6.1 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2024-2030. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$2.7 Billion by the end of the analysis period. Growth in the Neurothrombectomy Devices segment is estimated at 6.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.1 Billion While China is Forecast to Grow at 6.9% CAGR

The Neurovascular Devices / Interventional Neurology market in the U.S. is estimated at US$1.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$938.6 Million by the year 2030 trailing a CAGR of 6.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.9% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global Neurovascular Devices/Interventional Neurology Market - Key Trends & Drivers Summarized

What Are Neurovascular Devices and Why Are They Critical in Neurology?

Neurovascular devices are medical tools designed to treat disorders affecting the blood vessels in the brain and spine. These devices are essential for procedures like treating strokes, aneurysms, arteriovenous malformations (AVMs), and other vascular abnormalities in the central nervous system. The category includes products such as embolization coils, neurovascular stents, thrombectomy devices, and catheters, which allow interventional neurologists to perform minimally invasive procedures to restore normal blood flow and reduce the risk of hemorrhage or ischemia.

The importance of neurovascular devices has grown exponentially with the rise of interventional neurology, a field that focuses on using these devices to treat cerebrovascular diseases. Stroke, one of the leading causes of death and disability worldwide, is a primary condition treated with these tools. Minimally invasive neurovascular interventions offer significant advantages, such as faster recovery times, reduced risk of complications, and higher success rates compared to traditional open-brain surgery. As the global burden of stroke and aneurysms rises, neurovascular devices play a critical role in saving lives and improving outcomes for patients.

How Is the Neurovascular Devices Market Evolving?

The neurovascular devices market is evolving rapidly due to advances in technology and the growing preference for minimally invasive procedures. One of the key trends shaping the market is the development of next-generation thrombectomy devices, which are used to remove blood clots in patients with ischemic stroke. These devices have seen continuous innovation, with improvements in their design allowing for faster and more effective clot removal, which in turn reduces the time between stroke onset and treatment, improving patient outcomes. Mechanical thrombectomy is now considered the gold standard for acute ischemic stroke, leading to a surge in demand for these devices.

Another significant trend is the increasing use of flow diverters for the treatment of complex brain aneurysms. Flow diverters are stent-like devices designed to redirect blood flow away from an aneurysm, promoting healing of the vessel and preventing rupture. These devices offer a less invasive and more effective alternative to traditional coiling procedures for large or difficult-to-reach aneurysms. Additionally, the market is witnessing growth in demand for neurovascular access products such as guidewires and microcatheters, which are critical for delivering therapeutic devices to the brain with precision.

Which Conditions Are Driving the Adoption of Neurovascular Devices?

Several conditions are driving the increased adoption of neurovascular devices, with stroke being the most significant. Strokes, particularly ischemic strokes caused by blood clots, require immediate intervention to restore blood flow and prevent permanent brain damage. Neurovascular devices, such as stent retrievers and aspiration catheters, are essential for these life-saving procedures. Hemorrhagic strokes, which result from ruptured blood vessels, also demand the use of devices like aneurysm clips, coils, and flow diverters to prevent further bleeding and stabilize the patient.

Aneurysms are another major driver, as they can lead to life-threatening bleeding if they rupture. Minimally invasive interventions using devices like embolization coils or flow diverters allow for targeted treatment of aneurysms without the need for open surgery. Arteriovenous malformations (AVMs) and dural arteriovenous fistulas (DAVFs), which are abnormal connections between arteries and veins in the brain, are also treated using neurovascular devices. These conditions often require embolization or surgical resection, both of which rely on specialized tools to reduce the risk of rupture and bleeding.

What Are the Key Growth Drivers in the Neurovascular Devices Market?

The growth in the neurovascular devices market is driven by several key factors. The increasing prevalence of stroke and brain aneurysms globally is a major driver, particularly as aging populations face a higher risk of these conditions. Another critical factor is the growing demand for minimally invasive surgical procedures, which offer patients faster recovery times, reduced hospital stays, and lower rates of complications. As interventional neurology continues to advance, the demand for cutting-edge devices such as thrombectomy systems, stents, and embolization products is rising.

Technological advancements in neurovascular devices are also fueling market growth. The development of next-generation thrombectomy devices, flow diverters, and embolization coils with enhanced precision and safety features is expanding the range of treatable conditions. In addition, the increasing investments in healthcare infrastructure, especially in emerging markets, are boosting access to neurovascular treatments. Government initiatives focused on reducing stroke-related mortality and improving outcomes are also contributing to the market’s expansion, along with rising awareness of stroke prevention and early treatment.

SCOPE OF STUDY:

The report analyzes the Neurovascular Devices / Interventional Neurology market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems, Support Devices); Disease Pathology (Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas, Other Disease Pathologies); End-Use (Hospitals, Ambulatory Surgery Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W.L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Neurovascular Devices / Interventional Neurology - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Stroke and Neurovascular Disorders Drives Demand for Neurovascular Devices
    • Advancements in Minimally Invasive Interventional Neurology Techniques Propel Growth of Neurovascular Devices Market
    • Growing Use of Mechanical Thrombectomy Devices Strengthens Market for Ischemic Stroke Treatment
    • Increasing Adoption of Flow Diverters and Stents in Aneurysm Treatment Expands Market for Neurovascular Devices
    • Rising Demand for Embolization Coils in Brain Aneurysm and AVM Treatments Drives Market Growth
    • Advancements in Imaging Technologies and Real-Time Navigation Systems Propel Growth of Interventional Neurology Devices
    • Growing Focus on Minimally Invasive Clot Retrieval Expands Market for Aspiration Catheters in Stroke Intervention
    • Increasing Adoption of Neurovascular Devices in Treating Arteriovenous Malformations (AVMs) Expands Addressable Market
    • Emerging Focus on Liquid Embolics and Adhesives in Neurovascular Surgery Generates New Opportunities for Device Manufacturers
    • Technological Innovations in Neurovascular Stent Retrievers Strengthen the Business Case for Endovascular Stroke Treatment
    • Rising Prevalence of Aneurysms and Stroke in Aging Populations Propels Demand for Neurovascular Devices
    • Increasing Use of Balloon Catheters in Endovascular Procedures Drives Growth in Neurovascular Device Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neurovascular Devices / Interventional Neurology Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Aneurysm Coiling & Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Neurothrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Cerebral Aneurysms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ischemic Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Arteriovenous Malformation & Fistulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Disease Pathologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제